Search Tag: high intensity focused ultrasound
2014 05 Aug
The company marketing Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU), used to treat low-risk prostate cancer, has failed to get the nod of U.S. Food and Drug Administration (FDA) on its premarket approval application. HIFU, which has been used in other countries for about 15 years, is marketed in Europe by EDAP TMS, a French...Read more